Latest Breaking News On - Virtual rare disease forum - Page 1 : vimarsana.com

Published: Mar 16, 2021 NEW YORK, March 16, 2021 (GLOBE NEWSWIRE) Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today announced it will host a Virtual Rare Disease Forum on Tuesday, March 23 rd, 2021 from 1:00pm to 3:00pm ET. The event will highlight Applied Therapeutics’ development programs in Galactosemia, SORD Deficiency, and PMM2-CDG. The agenda for the event will include: Update on ACTION-Galactosemia Clinical Development Program Overview of SORD Deficiency, presented by Stephan L. Züchner, MD, PhD, Professor and Department Chair of Human Genetics at the University of Miami Miller School of Medicine

United statesJoseph muenzerMaeve conneightonShoshana shendelmanUniversity of north carolina children research instituteClinical development programVirtual rare disease forum onUniversity of miami miller school medicineDeficiency clinical developmentTherapeutics incVirtual rare disease forumApplied therapeuticGalactosemia clinical developmentDepartment chairHuman geneticsMiami miller school